Botulinum and tetanus neurotoxins are the most toxic substances known and form the growing family of clostridial neurotoxins. They are composed of a metalloprotease light chain (L), linked via a disulfide bond to a heavy chain (H). H mediates the binding to nerve terminals and the membrane translocation of L into the cytosol where their substrates, the three SNARE proteins, are localised. L translocation is accompanied by unfolding, and it has to be reduced and reacquire the native fold to exert its neurotoxicity. The Thioredoxin reductase-Thioredoxin system is responsible for the reduction, but it is unknown whether the refolding of L is spontaneous or aided by host chaperones. Here we report that geldanamycin, a specific inhibitor of heat shock protein 90, hampers the refolding of L after membrane translocation and completely prevents the cleavage of SNAREs. We also found that geldanamycin strongly synergises with PX-12, an inhibitor of thioredoxin, suggesting that the processes of L chain refolding and interchain disulfide reduction are strictly coupled. Indeed we found that the heat shock protein 90 and the Thioredoxin reductaseThioredoxin system physically interact on synaptic vesicle where they orchestrate a chaperone-redox machinery which is exploited by clostridial neurotoxins to deliver their catalytic part into the cytosol.
Introduction
The seven serotypes of botulinum neurotoxins (BoNTs), which include a very large number of sub-types (Smith et al. 2015b) , form with tetanus neurotoxin (TeNT) the family of clostridial neurotoxins (CNTs) (Rossetto et al. 2014) . BoNTs are the etiological agents of botulism, a neuroparalytic syndrome whose major symptom is a prolonged flaccid paralysis (Johnson and Montecucco 2008) whilst TeNT causes tetanus, a disease characterised by spastic paralysis which still is a major cause of death in non-vaccinated populations (Bercsenyi et al. 2014) . BoNTs and TeNT are very similar toxins, both from a structural and biochemical point of view, and their opposite clinical manifestations are because of their divergent journey inside the host (Caleo and Schiavo 2009; Rummel 2015) . Indeed, the main BoNT site of action is the neuromuscular junction where they block the release of acetylcholine, whilst TeNT reaches the spinal cord via retroaxonal transport and prevents the release of inhibitory neurotransmitters (Caleo and Schiavo 2009; Bercsenyi et al. 2013; Bercsenyi et al. 2014) .
CNTs are the deadliest substances known with lethal doses in the order of few nanograms/kilograms or lower (Gill 1982) . Such a toxicity is the result of an efficient molecular architecture evolutionary shaped to exploit essential processes of vertebrates neurophysiology (Montecucco and Rasotto 2015) . CNTs are composed by a metalloprotease L chain (L, 50 kDa) that is disulfide linked to a heavy chain (H, 100 kDa), which is responsible for neurospecific binding and delivery of L into host cytosol (Lacy et al. 1998; Swaminathan and Eswaramoorthy 2000; Kumaran et al. 2009 ). The C-terminal half of the H chain (HC) mediates the binding to peripheral nerve terminals (Montecucco 1986; Binz and Rummel 2009; Rummel 2013; Rossetto et al. 2014 ) and the ensuing intraneuronal trafficking which lead BoNTs inside the motor axon terminal (Colasante et al. 2013) or to the retrograde axonal transport of TeNT toward the spinal cord (Salinas et al. 2010; Bercsenyi et al. 2013; Rossetto et al. 2013; Bercsenyi et al. 2014) . The N-terminal half of H (HN) mediates the translocation of L across the membrane of the endocytic organelles (Koriazova and Montal 2003; Fischer and Montal 2007b, Fischer et al., 2007a; Montal 2010; Pirazzini et al. 2015a) . L specifically cleaves one of the SNARE proteins that form the core of the neuroexocytosis nanomachine (Binz 2013; Pantano and Montecucco 2014) : the L chains of BoNT/A and /E target SNAP-25 (Blasi et al. 1993a; Schiavo et al. 1993a; Schiavo et al. 1993b; Binz et al. 1994) , those of BoNT/B, /D, /F, /G and TeNT remove the largest part of the cytosolic domain of VAMP-1/2 (Schiavo et al. 1992; Schiavo et al. 1993a; Schiavo et al. 1993c; Schiavo et al. 1994; Yamasaki et al. 1994) whilst the L chain of BoNT/C cleaves SNAP-25 and some isoforms of Syntaxins (Blasi et al. 1993b; Vaidyanathan et al. 1999 ).
CNT's mechanism of nerve intoxication consists of five main steps (Pirazzini et al. 2015b ): (i) binding to nerve terminals, (ii) internalisation within endocytic compartments, (iii) low-pH induced translocation of L, (iv) cytosolic reduction of the interchain disulfide bond and (v) proteolysis of SNAREs. Among these several steps, the molecular mechanism underlying the translocation of the enzymatic domain into neuronal cytosol is the least understood (Pirazzini et al. 2015a ), although it is long known that the process is initiated by acidification (Simpson et al. 1994; Williamson and Neale 1994) . At low pH, HN and L undergo a concerted structural change that leads to the passage of the enzymatic domain across the membrane with the formation of an ionconducting channel (Montal 2010; Fischer and Montal 2013; Rossetto et al. 2014; Pirazzini et al. 2015a) . It is not clear if channel formation is a prerequisite or a consequence of translocation (Pirazzini et al. 2015a ), but it is reported that L has to undergo partial unfolding in order to cross the membrane (Fu et al. 2002; Fischer and Montal 2007a; Galloux et al. 2008) . In fact, cargo proteins, which do not unfold at low pH attached to the amino terminus of BoNTs, drastically reduce the delivery of the L into cell cytosol (Bade et al. 2004) . As a result of its unfolding, once it has reached the cytosolic face of the membrane, the L chain has to reacquire the native structure in order to cleave its substrates. It is presently unknown whether this process is spontaneous or it is assisted by host chaperone proteins, which normally reside on the organelle membrane (Smith et al. 2015a) .
The involvement of host chaperones such as heat shock protein 90 (Hsp90), peptidyl prolyl cis/trans isomerases (PPIases) and protein disulfide isomerase (DPI) in the entry of several plant and bacterial exotoxins into the cell cytosol has been documented (Tsai et al. 2001; Haug et al. 2003; Ratts et al. 2003; Bellisola et al. 2004; Haug et al. 2004; Barth 2011; Dmochewitz et al. 2011; Kaiser et al. 2011) .
Recently, we found that the Thioredoxin reductasethioredoxin system (TrxR-Trx) is responsible for the cytosolic reduction of BoNTs and TeNT interchain disulfide bond (Pirazzini et al. 2013a; Pirazzini et al. 2014; Pirazzini et al. 2015b; Zanetti et al. 2015) , a molecular event which ends the translocation step (Fischer and Montal 2007a; Montal 2010; Fischer 2013) , and it is a prerequisite to free the metalloprotease activity (Schiavo et al. 1992; Schiavo et al. 1993a; Schiavo et al. 1993b) . Because TrxR and Hsp90 were previously found to be fundamental in mediating both the refolding and the release of diphtheria toxin catalytic subunit (Ratts et al. 2003) , in the present study, we have tested the possible involvement of this cytosolic chaperone also in the uptake of CNT enzymatic domain inside neurons. Using geldanamycin (GA), a specific and potent inhibitor of Hsp90, we found that this drug prevents CNT toxicity in primary cell culture. We demonstrate that GA interferes with the translocation process, most likely by inhibiting the cytosolic refolding of L, but not with the other essential steps of CNT mechanism of intoxication. Moreover, by blocking at the same time Hsp90 and the TrxR-Trx system, we observed a strong synergistic inhibitory effect indicating a combined action of these systems in the entry of the L chain into the cytosol.
Results

Hsp90 pharmacological inhibition protects primary neurons from CNT intoxication
The involvement of Hsp90 in the uptake of several bacterial toxins was suggested by pharmacological studies using specific inhibitors (Haug et al. 2003; Ratts et al. 2003; Haug et al. 2004; Taylor et al. 2010; Barth 2011; Kaiser et al. 2011; Burress et al. 2014; Ernst et al. 2015) . The most specific one, geldanamycin, is a benzoquinone antibiotic that binds the ATP-binding pocket of Hsp90 thereby inhibiting its chaperone activity (Stebbins et al. 1997) . To test the possible involvement of Hsp90 in CNT entry, primary cerebellar granule neurons (CGNs) were treated either with BoNTs or TeNT in the presence of GA, and their toxicity was evaluated using two complementary read-outs: Western blotting (WB) and immunofluorescence (IF) (Fig. 1-Fig. 2 ). We started with BoNT/A that, together with BoNT/B, is responsible for most cases of human botulism (Johnson and Montecucco 2008) and is almost invariably used in human therapy (Montecucco and Molgo 2005; Hallett et al. 2013; Naumann et al. 2013) . When the L chain of BoNT/A enters the cytosol, it cleaves SNAP-25, and its truncated form can be quantified by WB (Fig. 1A, lane PC) . The same phenomena can be evaluated via IF analysis, which provide complementary information (Fig. 1B, middle panel) . BoNT/A, at the concentration used here, cleaves SNAP-25 almost completely, as determined with an antibody that recognises both the intact and the cleaved form of SNAP-25 (Fig. S1 ). Whatever the read-out used, addition of GA significantly protects neurons from BoNT/A. Its inhibitory activity is concentration dependent and reaches its maximum already at 12.5 μM, as indicated by the absence of SNAP-25 BoNT/A truncated form in WB (Fig. 1A and Fig. S1 ) and IF (Fig. 1B , compare middle with right panel). As Hsp90 is involved in multiple aspects of cell physiology (Saibil 2013) , GA is highly toxic. Accordingly, the experiment was conducted by pretreating CGNs with GA for 30 min and concluded within 4 h after toxin addition to avoid the drug toxicity; under the experimental conditions used here cell viability was not significantly affected (Fig. S2 ).
Investigations were extended to other members of CNTs family, serotype D of BoNT (BoNT/D), a major cause of animal botulism (Lindstrom et al. 2010) and TeNT, which is the toxin responsible for tetanus. We choose these CNTs also because, at variance from BoNT/A, they cleave VAMPs and at two different peptide bonds (Schiavo et al. 1992; Schiavo et al. 1993a) . Fig. 2A and Fig. 2C show that these two toxins cause the complete disappearance of VAMP-2 staining and that the addition of GA caused a remarkable and concentration-dependent protection from such a specific proteolysis. Consistently, IF analysis ( Fig. 2B and Fig.  2D ) shows that these two neurotoxins cause in CGNs a clear decrease of VAMP-2 (middle panels) that is prevented by treating neurons with GA (right panels).
Taken together, these data clearly indicate that, despite the different protein receptors and intracellular substrates, the inhibition of Hsp90 prevents the entry of enzymatically active L chains into the host cell cytosol and the ensuing cleavage of their respective cytosolic substrates.
The involvement of molecular chaperones different from Hsp90 in membrane translocation of several exotoxins was previously suggested (Dmochewitz et al. 2011; Kaiser et al. 2011; Ernst et al. 2015; Ernst et al. 2016) . Accordingly, we took advantage by the existence of specific inhibitors such as cyclosporine A which specifically targets Cyclophilin A (Handschumacher et al. 1984) , and VER-155008, a general inhibitor of the ATPase activity of Hsp70s to test the possible role in CNT toxicity of these chaperones. We also synthetised an Acridizinium derivative, dubbed 'compound 2', which was recently reported to inhibit Hsc70 (Ernst et al. 2016) , the constitutively expressed isoform of Hsp70, one of the chaperones of the synaptic vesicles (SV) (Tobaben et al. 2001; Sharma et al. 2011) . Remarkably, none of these molecules had a significant effect on the activity of the L chains of BoNT/A (Fig. S3 ), strongly suggesting that Hsp90 plays a principal role in supporting CNT toxicity.
Geldanamycin inhibits the L chain refolding after its pH-dependent membrane translocation
The remarkable inhibitory activity of GA on BoNT/A, BoNT/D and TeNT cleavage of their SNARE substrates called for a study of its effect on the various steps of their mechanism of action in order to identify which of them is affected.
First, we investigated whether the inhibition of Hsp90 prevents the binding of CNTs to CGN plasma membrane and their subsequent internalisation. Neurons were A. CGNs were pretreated for 30 min with the indicated concentrations of GA at 37°C; then BoNT/A was added (2.5-nM final concentration), and the incubation prolonged for 3.5 h. Thereafter, neurons were lysed, and the cleavage of SNAP-25 estimated with a specific antibody against the BoNT/A truncated form. VAMP-2 and Syntaxin 1A were used as loading controls. A typical immunoblot is reported on the left, whilst the right panel shows the quantification of cleaved SNAP-25 as a ratio to Syntaxin 1A, taking the value in nontreated cells (NC) as 100%. SD values derive from at least three independent experiments performed in triplicates. B. Neurons were treated as described in A, but the experiment was stopped by fixation and the presence of SNAP-25 A evaluated via IF, using an antibody specific for the BoNT/A truncated form. All the images are representative of three independent experiments.
Hsp90 chaperones the L chain refolding of CNTs 3 of 12 pretreated either with vehicle or with GA at a concentration causing complete inhibition of BoNT/A activity. CGNs were then incubated for 30 min with the BoNT/A binding domain fused to circularly permutated Venus (cpV-HC/A), used as reporter for WB analysis. Fig. 3A shows that binding and internalisation of cPV-HC/A were not affected by GA. The same experiment was repeated using as reporter an antibody against the SV integral membrane protein synaptotagmin-1 (Ab-Syt1). Ab-Syt1 recognises a portion of the protein transiently exposed to cell medium upon fusion of SVs with the plasma membrane. Accordingly, the amount of antibody taken up by neurons can be used as an indirect method to check the overall functionality of SV dynamics (Kraszewski et al. 1995) . In fact, Fig. S4 shows that in control condition neurons incorporate Ab-Syt1, which can be detected by WB (lane vehicle). On the contrary, when BoNT/D cleaves VAMP-2 and prevents the assembly of a functional SNARE complex, SV dynamics is impaired and CGNs do not uptake the antibody (lane BoNT/D). Figure  S4 also shows that GA treatment (lane GA) does not impinge on the amount of internalised Ab-Syt1, which is comparable to that of vehicle-treated neurons, suggesting that SV functionality is not altered by GA.
These two complementary approaches therefore indicate that Hsp90 inhibition does not affect toxin binding and endocytosis in cultured neurons.
Next, we investigated the effect of GA on endosome acidification, which is strictly required for the membrane translocation of the L chains of all CNTs (Simpson 1983; Rossetto et al. 2014) . We used Lysotracker Red DND-99, a dye which labels and tracks acidic organelles in living cells. Fig. 3B shows that GA does not interfere with organelle acidification at variance from bafilomycin A1, which is a specific inhibitor of the vacuolar H + -ATPases (Bowman et al. 1988) , and is used here as positive control.
Finally, Fig. 3C shows that GA does not interfere with the metalloproteolytic activity of CNTs on SNAREs, using BoNT/D cleavage on VAMP-2 as an example.
Taken together the results present here indicate that Hsp90 is involved in assisting and promoting the refolding of the metalloprotease L chain after its translocation into the cytosol. If this is the case, GA is expected to impact directly on the translocation process. To test this idea, we took advantage of an intoxication method, named 'pH jump', which by-passes internalisation and induces the entry of L into the cytosol directly from the plasma membrane (Sandvig and Olsnes 1980; Sandvig and Olsnes 1981; Pirazzini et al. 2011; Pirazzini et al. 2013c; Azarnia Tehran et al. 2015) . As shown in Fig. 4 , by lowering the pH to 4.5, BoNT/D L chain is productively translocated across the plasma membrane of CGNs and delivered into the cytosol in its active form, as indicated by the cleavage of VAMP-2 (lane 'pH 4.5'). The assay is amenable to manipulation; indeed the delivery of the L chain, and the ensuing cleavage of VAMP-2, can be prevented by PX-12 (lane PX-12), a known inhibitor of Trx (Kirkpatrick et al. 1998) which blocks the release of the metalloprotease in the cytosol by interfering with the reduction of the interchain disulfide bridge Zanetti et al. 2015) . Accordingly, the absence of VAMP-2 cleavage upon treatment with GA (lane GA) suggests that this drug directly impacts on the translocation, likely on the L chain refolding.
Hsp90 and TrxR-Trx are present on synaptic vesicles and are essential to the release of active L chain in the cytosol
The effect of PX-12 indicates the essential role of the Thioredoxin reductase-Thioredoxin system in reducing the interchain disulfide bond as a prerequisite for the intracellular activity of the L chain Rossetto et al. 2014 ). This redox system was previously suggested to form with Hsp90 a complex that plays an essential role in the entry of diphtheria toxin into the cytosol from the lumen of endosomal compartments (Ratts et al. 2003) . As the CNTs are similarly composed of a catalytic domain disulfide-linked to a subunit mediating binding and translocation, we reasoned that disulfide reduction and cytosolic refolding may be coupled and that Hsp90 may act in concert with the TrxR-Trx system to enable the catalytic activity of the L chain in the cytosol. If this is the case, GA and PX-12 should synergise, whilst if the two systems do not act in a Fig. 3 . Geldanamycin has no effect on CNTs binding, endosome acidification and in vitro metalloprotease activity. A. CGNs were pretreated with geldanamycin (GA, 12.5 μM) or vehicle (DMSO) at 37°C for 30 min after which, cpV-HC/A (250 nM final concentration) was added in high K + buffer for further 30 min. Neurons were then washed, lysed and the cpV-HC/A amount was estimated by WB with an antibody against GFP. Syntaxin 1A, SNAP-25 and VAMP-2 are used as loading controls. In the first lane (input) 50 ng of the cpV-HC/A were loaded as reference. The immunoblot is representative of three independent sets of experiments. B. CGNs were treated with vehicle (DMSO) or 12.5 μM of GA or 50 nM bafilomycin A1 for 30 min at 37°C. Then, Lysotracker Red was added for 1 h, and neurons were imaged by fluorescence microscopy. Images are representative of two independent experiments. C. BoNT/D (100 ng) was reduced with 10 mM DTT with or without 12.5 μM GA for 30 min at 37°C before adding 1 μg of GST-VAMP-2. The reaction was carried out for 4 h at 37°C. VAMP-2 cleavage was assessed by SDS-PAGE. A representative image is shown.
Hsp90 chaperones the L chain refolding of CNTs 5 of 12 concerted way, the simultaneous presence of the two inhibitors should give an additive effect. CGNs were treated with either PX-12 or GA or with their combination at concentrations which do not cause by themselves very slight inhibition (2.5 μM each; Fig. S5 ). Fig. 5 shows that a very high level of inhibition is achieved in this way, strongly supporting the possibility of a concerted action of Hsp90 and TrxR-Trx in enabling the proteolytic activity of the L chain.
This result prompted us to assay for a physical interaction between Hsp90 and TrxR-Trx on SVs, the organelle wherefrom BoNT/A translocates its L chain (Colasante et al. 2013 ). Fig. 6A shows that rat brain synaptosomes contain both Hsp90 and TrxR-Trx and that both proteins are also present on isolated SVs. Intriguingly, the relative amount of Hsp90 increases in the fraction of docked SVs, as it is the case for TrxR and Trx , favouring the possibility of their direct interaction on the cytosolic face of SV. Starting from crude SVs, i.e. a pool of free and docked SVs, we immunoprecipitated Hsp90 and assayed by WB for the presence of TrxR and Trx. Fig. 6B shows that the three proteins physically interact and precipitate together with Rab3a which was previously reported to co-immunoprecipitate with Hsp90 (Sakisaka et al. 2002) .
Discussion
The results reported here are part of a large effort of this laboratory aimed at the identification of small-molecules inhibitors capable of preventing the neurotoxicity of BoNTs regardless of their different sequences and immunological properties (Montal 2014; Pirazzini et al. 2015b) . In fact, the growing number of BoNTs calls for the research of paninhibitors, i.e. molecules whose action does not depend on toxins specific antigenicity as it is the case of serotypebased treatments and vaccines (Smith et al. 2005; Kalb et al. 2011) . So far, research on small-molecules inhibitors was aimed at inhibiting the proteolysis of SNAREs, as such strategy can in principle be effective after the L chain has entered into nerve terminal cytosol. However, the recognition and binding of the L chains to their substrates require extended interactions involving the active site and a number of exosites (Rossetto et al. 1994; Pellizzari et al. 1996; Breidenbach and Brunger 2004; Agarwal et al. 2009; Brunger and Rummel 2009; Binz et al. 2010; Pantano and Montecucco 2014) , and this situation undermined these efforts. We pursued a different approach based on the knowledge about the steps of the mechanism of neuron intoxication that are shared by all BoNT serotypes (Rossetto et al. 2014; Pirazzini et al. 2015b ).
Here we show that geldanamycin, a specific inhibitor of a major heath shock protein, Hsp90, strongly prevents the activity of three prototypes of CNTs on neuronal cultures. This finding indicates that Hsp90 assists the refolding of the metalloprotease L chains of CNTs after membrane crossing in an unfolded structure (Koriazova and Montal 2003; Fischer 2013; Pirazzini et al. 2015a) . Interestingly, this is the first report showing Hsp90 come into play for the entry of toxin catalytic subunits which are not ADPribosyltransferase. This entails that Hsp90 involvement is not linked to a specific class of enzyme, at least in the case of CNTs, as previously suggested (Barth 2011 ). We do not know which are the common molecular features rendering CNT L chains and ADP-ribosyltransferases similarly reactive to this chaperone; however, it must be considered that, generally, Hsp90 does not recognise its client proteins via specific protein-protein interactions or motifs. Indeed, Hsp90 is not a 'folding catalyst', i.e. it does not control the rate of protein folding in a direct way such as DPI or PPI, rather it recognises unfolded intermediates with secondary structure preventing their aggregation (Jakob et al. 1995) . Interestingly, Hsp90 has a preference for positively charged substrates (Csermely et al. 1997) , making the catalytic chain of CNTs an ideal substrate during translocation, as the low pH induces L to acquire a positive charge following carboxylates neutralisation (Pirazzini et al. 2011; Pirazzini et al. 2013b; Pirazzini et al. 2015a) . Accordingly, the interaction of Hsp90 with the three different L chains tested here may be because of a hydrophobic binding activity of Hsp90 that prevents improper folding or aggregation of the unfolded L chain emerging from the membrane in the cytosol, rather than on specific protein-protein interaction.
We also investigated the involvement of other chaperons and in particular of Hsc70 that, together with cysteine string protein and small glutamine-rich tetratricopeptide repeatcontaining protein, forms the tripartite chaperone machine residing on SV (Tobaben et al. 2001) . Surprisingly, the pharmacological inhibition of this protein did not interfere with toxin activity, underscoring the primary role of Hsp90. Therefore, the involvement of Hsp90 in CNTs entry may be related to the concomitant presence of this chaperone and the thioredoxin system on SVs (Takamori et al. 2006; Morciano et al. 2009; Pirazzini et al. 2014) and to their physical and functional interaction, a possibility reinforced by the synergistic effect that we found among GA and PX-12. Together with the findings that Hsp90 and TrxR orchestrate the entry of the enzymatic subunit of diphtheria toxin in the cytosol and that auranofin, the most potent inhibitor of TrxR (Omata et al. 2006) , blocks the entry of diphtheria toxin (Schnell et al. 2015) , as GA does (Ratts et al. 2003) ; these results suggest that DT and CNTs have evolved a mode of membrane translocation that exploits a similar cytosolic chaperone machinery. We did not investigate the physiological role of this couple; however, it was previously reported that in nerve terminals Hsp90 interacts with αGDI, and this interaction coordinates neurotransmitter release (Gerges et al. 2004 ) by (Thioredoxin  reductase) , VAMP-2 (synaptobrevin-2), Tom20 (translocase of outer membrane) and Trx1 (Thioredoxin 1). B. Hsp90-interacting proteins were recovered by immunoprecipitation. A crude synaptic vesicle fraction was isolated from 2 mg of rat brain synaptosomes and incubated with Protein G-decorated beads coupled (or not as a control) to a monoclonal antibody specific for Hsp90. After overnight incubation at 4°C beads were washed and Hsp90 interactors were processed for WB to assess the presence of TrxR and Trx1. The staining for Na + /K + ATPase (Sodium-Potassium pump), Syp (synaptophysin) or Tom20 was used to test for the residual presence of plasma membrane, SVs and mitochondria, respectively; Rab3a (Ras-related protein 3a) staining was used as a positive control for known interactors (Sakisaka et al. 2002) . In the first lane (input) 5 μg of crude synaptic vesicles fraction was loaded as reference.
Hsp90 chaperones the L chain refolding of CNTs 7 of 12 regulating the extraction of Rab3A from SVs (Sakisaka et al. 2002) . Considering that the association of αGDI to Rab proteins is strongly dependent on its redox state (Chinni et al. 1998; Felberbaum-Corti et al. 2007) , the role of TrxR-Trx redox system within the chaperone complex may be that of managing the many cysteines present on the αGDI structure.
Experimental procedures
Botulinum neurotoxin inhibition assay
CGNs at 6-8 days in vitro were treated for 30 min with the indicated concentration of GA in complete culture medium at 37°C and 5% CO 2 . Thereafter, 2.5 nM BoNT/A or 0.5 nM TeNT in complete medium was added and left for 3.5 h at 37°C and 5% CO 2 . In the case of BoNT/D, owing to its potency, the toxin was added as pulse of 15 min at a concentration of 0.01 nM. The neuronal culture was then washed, and the culture medium with the same concentration of inhibitor was restored for 195 min.
cpV-HC/A binding and internalisation assay
CGNs were treated with GA 12.5 μM or vehicle (DMSO) in culture medium at 37°C. After 30 min, 250 nM cpV-HC/A was added and the concentration of KCl increased at 57 mM. After 30 min, neurons were washed twice with PBS, lysed and immunoblotted. cpV-HC/A was detected with an anti-GFP antibody (Cell Signaling, #2956).
Maturation of acidic compartment assay
CGNs at 6-8 DIV were treated for 30 min with vehicle (DMSO) or 12.5 μM GA or 10 nM bafilomycin A1 in complete culture medium supplemented with 6.25 mM HEPES at 37°C and 5% CO 2 ; 75 nM Lysotracker® Red DND-99 was added for 60 min. Cells were then washed with Krebs-Ringer buffer (KRH: 128 mM NaCl, 2.5 mM HEPES, 4.8 mM KCl, 1.3 mM CaCl 2 , 1.2 mM MgSO 4 and 1.2 mM K 2 HPO 4 ), and images of living neurons were acquired with a Leica CTR6000 microscope.
In vitro proteolytic activity
BoNT/D (0.1 μg) was incubated in reducing buffer (150 mM NaCl, 10 mM NaH 2 PO 4 , 15 mM DTT pH 7.4) in the presence of 12.5 μM GA for 30 min at 37°C or vehicle (DMSO). Then 1 μg of recombinant GST-VAMP-2 (1-96) was added to the reduced toxins, the concentration of inhibitor or vehicle was restored and the reaction was carried out for 4 h at 37°C. VAMP-2 cleavage was assessed by SDS-PAGE.
Low pH induced translocation of BoNT/D across the plasma membrane
CGNs at 6-8 DIV were treated with vehicle (DMSO) of different concentrations of GA or PX-12, or their combination for 30 min at 37°C, 5% CO 2 . Neurons were washed twice with cold culture medium and subsequently incubated with 200 pM of BoNT/D in ice-cooled medium (pH 7.4) and left at 4°C for 15 min. After washing twice with the same cold medium, pre-warmed (37°C) medium A (123 mM NaCl, 6 mM KCl, 0.8 mM MgCl 2 , 1.5 mM CaCl 2 , 5 mM NaP i , 5 mM citric acid, 5.6 mM glucose, 10 mM NH 4 Cl), adjusted at pH 7.4 or 4.5, was added for 10 min in the presence of vehicle or of inhibitors (alone or in combination). Cells where then washed twice and further incubated, for 3.25 h, in normal culture medium (pH 7.4) supplemented with 50 nM Bafilomycin A1 and containing inhibitors.
Hsp90 immunoprecipitation
Immunoprecipitation of Hsp90 was carried out as previously reported (McMahon and Nicholls 1991): 2 mg of rat brain synaptosomes was re-suspended in buffer B (20 mM HEPES, 140 mM NaCl, 5 mM KCl, 5 mM NaHCO 3 , 1.2 mM Na 2 HPO 4 , 1 mM MgCl 2 and 10 mM glucose, pH 7.4) and subjected to osmotic shock using H 2 O in the presence of protease inhibitors for 30 min at 4°C. Sample was subjected to three passages through 18 G needles and three through 27 G needles and then centrifuged for 5 min at 10 000 × g. The resulting supernatant was centrifuged for 1 h at 80 000 r.p.m.
to yield a crude SV fraction in the pellet and a cytosolic fraction in the supernatant (Stahl et al. 1996) . The pellet fraction was resuspended in buffer B and incubated overnight at 4°C with G 
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Supporting Information
Additional Supporting Information may be found in the online version of this article at the publisher's web-site: Fig. S1 . Hsp90 inhibition prevents BoNT/A-mediated cleavage of SNAP-25 in CGNs. Experiment was conducted as in Fig. 1 ; thereafter, neurons were lysed and SNAP-25 cleavage was estimated with an antibody that recognises both the intact and truncated form; Syntaxin 1A and VAMP2 were used as loading control. A typical immunoblot is reported (NC, only vehicle; PC, only BoNT/A; the six following lanes refer to samples pretreated with different GA concentrations: 12.5, 10, 7.5, 5, 2.5, 1 μM). Typical WB are shown. NC, only vehicle; PC, only BoNT/A; the six following lanes refer to samples treated with toxin plus different inhibitor concentrations: 50, 40, 30, 20, 10, 5 μM for CsA and VER-155008; 5, 2.5, 1, 0.5, 0.25, 0.1 μM for compound-2. Fig. S4 . Geldanamycin does not affect synaptic vesicles dynamics. CGNs were treated as in Fig. 3A but using as reporter of SVs dynamics an antibody against the lumenal domain of Synaptotagmin-1. Where indicated, BoNT/D was added before starting GA treatment. The internalised antibody was detected by WB, using directly a secondary antibody. Syntaxin 1A and SNAP-25 were considered as loading controls; instead, VAMP-2 staining was used to assess BoNT/D cleavage. In the first lane (input) 50 ng of the anti-Synaptotagmin 1 antibody was loaded as reference. The immunoblot is representative of three independent sets of experiments. Fig. S5 . PX-12 and geldanamycin inhibit the translocation of BoNT/D L chain across the plasma membrane in a concentration-dependent manner. CGNs were like in Fig. 4 using the indicated concentrations of PX-12 (A) or GA (B). The translocation of BoNT/D was assessed by monitoring the cleavage of VAMP-2, determined via WB (top panels). Bottom panels show the amount of intact VAMP-2 reported as a ratio to Syntaxin 1A which served as loading control, taking the value in pH 7.4 treated cells as 100%. All data are presented as mean values with SD values arising from three independent experiments.
